The FDA Calendar provides a centralized view of upcoming PDUFA (Prescription Drug User Fee Act) decision dates for publicly traded biopharmaceutical companies. It helps investors and analysts track key FDA approval milestones that can significantly impact stock performance. Each entry includes the company name, ticker, drug candidate and expected decision date.